Citation

Irwin PH. Eval. Program Plann. 1981; 4(2): 123-130.

Copyright

(Copyright © 1981, Elsevier Publishing)

DOI

10.1016/0149-7189(81)90002-1

PMID

unavailable

Abstract

Quality of life assessment is used as an outcome measure technique to evaluate a central medical intake (CMI) unit for drug treatment programs. While significant improvements across time are evident in both perceived well-being and in the standard federal funding criteria, no differences are observed between those referred into treatment by the CMI and those entering directly. Moreover, the improvements observed are the same regardless of whether the patient stayed in treatment or not.